Solventum Health - SOLV Enterprise Value to EBITDA Ratio
The integration of AI into Solventum Corporation (SOLV) medical documentation reduces the burden on physicians, a trend the GURU.Markets platform reflects via the EV/EBITDA multiple on the time chart, where the 16.75 mark represents the latest data. Massive post-spin-off liabilities and market competition for consumables could dampen profits. Meanwhile, process restructuring creates challenges, although demand for products remains stable.
solventum.com (SOLV) - metric breakdowns and financial figures
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
- business earnings and investment ratios data:
SOLV - Profit After Payment of Taxes|Future Profit Solventum Corporation|SOLV - P/E Multiple|Future Price to Earnings Solventum Corporation|SOLV - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Solventum Health|SOLV - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Solventum|SOLV - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months solventum.com|SOLV - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Solventum Corporation
Summary company analytics:Solventum Inc. SOLV
The integration of medical systems and equipment at Solventum Corporation (SOLV) requires significant capital expenditures, making the company's EV/EBITDA chart a key analytical tool. This metric compares the total enterprise value, including net debt, with operating profit before depreciation and amortization. An increase in this ratio amid falling EBITDA signals asset overvaluation or a critical debt burden. Stability in this indicator confirms the ecosystem's ability to generate sufficient cash flow to service its obligations.
Competitor analysis
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCA Healthcare HCA|THC: Enterprise Value to Operating Income Before Depreciation|FMS: Enterprise Value to EBITDA Ratio|encompasshealth.com - Enterprise Value to Operating Income Before Depreciation Ratio|uhsinc.com (UHS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|DVA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RadNet Corp|Company Value to EBITDA Option Care Corp OPCH|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surgery Partners, Inc. (SGRY)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PINC (premierinc.com)|National Vision - Enterprise Value to EBITDA Ratio|Progyny Inc - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Ardent Health Partners Inc - EV/EBITDA Multiple|Company Value to EBITDA Select Medical Inc.|Astrana Health, Inc. (ASTH) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MD|Enterprise Value to EBITDA Ratio USPH|PNTG (Pennant Group) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ORGO (Organogenesis Inc.)|EV/EBITDA Multiple Nutex Health Hospitals (NUTX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Auna SA AUNA|SBC - Enterprise Value to EBITDA Ratio|EOLS: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation CYH (CHS)|SKIN: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MediWound|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization biote Corp.|Company Value to EBITDA thejoint.com JYNT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DocGo (DCGO)|PIII (p3hp.org) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Gain Therapeutics, Inc. GANX|EUDA (euda.com) - Company Value to Operating Income Before Depreciation Ratio|BMGL - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA CollPlant Biotechnologies|Cuprina Holdings (CUPR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Concord Medical Services Holdings - Business Value to Operating Income Before Depreciation|AMS (American Shared Hospital Services, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple MEDIROM Corp|Enterprise Value to EBITDA Ratio ALBT (Avalon GloboCare)|Enterprise Value to Operating Income Before Depreciation Ratio DHAI|EV/EBITDA Multiple XAGE (Carmell Therapeutics)|Total Company Value to Operating Income Before Depreciation Ratio NewGenIvf Group (NIVF)|ATIP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA CareMax, Inc|Kindly MD, Inc. (KDLY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MODV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Novo Integrated Sciences, Inc.|SunLink Health Systems, Inc (SSY) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMAC Regeneration Centers (BACK)
